z-logo
open-access-imgOpen Access
FHL 2 promotes tubular epithelial‐to‐mesenchymal transition through modulating β‐catenin signalling
Author(s) -
Cai Ting,
Sun Danqin,
Duan Ying,
Qiu Yumei,
Dai Chunsun,
Yang Junwei,
He Weichun
Publication year - 2018
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/jcmm.13446
Subject(s) - gene knockdown , epithelial–mesenchymal transition , microbiology and biotechnology , catenin , fibronectin , chemistry , smad , phosphorylation , biology , signal transduction , cancer research , extracellular matrix , downregulation and upregulation , cell culture , gene , wnt signaling pathway , biochemistry , genetics
Abstract β‐Catenin signalling plays an important role in regulating tubular epithelial‐to‐mesenchymal transition ( EMT ), an indispensable programme for driving renal fibrosis. As an adapter protein, four and a half LIM domain protein 2 ( FHL 2) acts as a coregulator of β‐catenin in several other cell types. To determine whether FHL 2 affects β‐catenin signalling and thus is involved in tubular EMT , we examined its expression and function in the process of TGF ‐β1‐induced EMT . FHL 2 mRNA and protein were induced by TGF ‐β1 in rat tubular epithelial cells ( NRK ‐52E), an effect that intracellular Smad signalling was required. Ectopic expression of FHL 2 inhibited E‐cadherin and enhanced α‐smooth muscle actin (α‐ SMA ) and fibronectin expression, whereas knockdown of FHL 2 partially restored E‐cadherin and reduced α‐ SMA and fibronectin induction stimulated by TGF ‐β1. Overexpression of FHL 2 increased β‐catenin dephosphorylation (Ser37/Thr41), nuclear translocation and β‐catenin‐mediated transcription and up‐regulated expression of β‐catenin target, EMT ‐related genes, such as Snail, Twist, vimentin, plasminogen activator inhibitor‐1 and matrix metalloproteinase‐7. Conversely, knockdown of FHL 2 increased β‐catenin phosphorylation (Ser33/37/Thr41), decreased its nuclear translocation and inhibited β‐catenin‐mediated transcription and target genes expression. TGF ‐β1 induced a FHL 2/β‐catenin interaction in NRK ‐52E cells, especially in the nuclei. In a mouse model of obstructive nephropathy, FHL 2 mRNA and protein were induced in a time‐dependent fashion, and the extent and pattern of renal β‐catenin activation were positively correlated with FHL 2 induction. Collectively, this study suggests that FHL 2, via modulating β‐catenin signalling, may implicate in regulation of TGF ‐β1‐mediated tubular EMT and could be a potential therapeutic target for fibrotic kidney disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here